Notícias Elutia Inc - ELUT | Ações NASDAQ

Monitor
Book
Fórum
Rankings
Portfolio
Mundo
Trader Chat
Scanner
Mais

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.

AI Entrar

Premium

Suporte
(11) 4950 5808
suporte@advfn.com.br
Fale Conosco

Início
Investir
Ações
EUA
NASDAQ
Elutia Inc (ELUT)
Elutia Inc (ELUT) Notícias

Elutia Inc (ELUT)

3,45

0,05

(1,47%)

Fechado 04 Janeiro 6:00PM

Atrasado por 15 minutos

3,405

-0,045

(-1,30%)

Após o horário de negociação: 9:59PM

Atrasado por 15 minutos

NASDAQ

ELUT

Elutia

Gráfico
Book
Fórum
Negócios
Notícias
Balanços

Dados

Notícias

Ferramentas

Mercados

Comunidade

Recursos principais

Follow Feed

Fluxo de Opções

Monitor

Elutia Inc (ELUT)

Capacite seu portfólio: Discussões em tempo real e ideias de negociação acionáveis.

Notícias de ELUT

Elutia Awarded Cardiac Rhythm Management Devices Agreement with Premier, Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025

Elutia to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Elutia to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024

Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form 8-K - Current report

Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company’s Antibiotic-Eluting BioEnvelope for Implantable Devices

Elutia Celebrates First Year

Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators

Elutia to Participate in Upcoming Investor Conferences

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Fóruns

Seu Histórico Recente

Empresa

Negócios

Popular

Obter o aplicativo

Tendências Agora

Rankings

Dados

Notícias

Ferramentas

Mercados

Comunidade

Recursos principais

Follow Feed

Fluxo de Opções

Monitor

Elutia Inc (ELUT) Notícias

Elutia Inc (ELUT)

Capacite seu portfólio: Discussões em tempo real e ideias de negociação acionáveis.

Notícias de ELUT

Elutia Awarded Cardiac Rhythm Management Devices Agreement with Premier, Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025

Elutia to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Elutia to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024

Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form 8-K - Current report

Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company’s Antibiotic-Eluting BioEnvelope for Implantable Devices

Elutia Celebrates First Year

Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators

Elutia to Participate in Upcoming Investor Conferences

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Fóruns

Seu Histórico Recente

Empresa

Negócios

Popular

Obter o aplicativo